Optiver Holding
PCVX icon

Optiver Holding’s Vaxcyte PCVX Stock Holding History

Optiver Holding’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.5K Buy
731
+434
+146% +$23.6K ﹤0.01% 1206
2026
Q1 		$17.3K Sell
297
-39
-12% -$2.12K ﹤0.01% 1126
2025
Q4 		$15.5K Sell
336
-303
-47% -$13.6K ﹤0.01% 1071
2025
Q3 		$23K Buy
639
+93
+17% +$3.08K ﹤0.01% 935
2025
Q2 		$17.8K Buy
546
+210
+63% +$6.88K ﹤0.01% 869
2025
Q1 		$12.7K Buy
+336
New +$26.9K ﹤0.01% 823

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Optiver Holding's PCVX Position: Q2 2026 in Review

Optiver Holding increased its Vaxcyte (PCVX) stake by 146% in Q2 2026, buying an estimated $23.6K and bringing the position to 731 shares worth $42.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1206.

Optiver Holding first reported a position in PCVX in Q1 2025 and has held it in 6 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Optiver Holding held 731 shares of Vaxcyte worth $42.5K as of Q2 2026.
  • Optiver Holding bought 434 Vaxcyte shares in Q2 2026, an estimated $23.6K.
  • Vaxcyte made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1206 holding.
  • Optiver Holding first reported a position in Vaxcyte in Q1 2025 and has held it in 6 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.